Back to Oncology Drug index
Name: Vinblastine Sulfate
Pregnancy Category D
- Mitotic inhibitor
- Antineoplastic agent
Affects cell energy production required for mitosis and interferes with
nucleic acid synthesis; has antimitotic effect and causes abnormal
Palliative treatment for generalized Hodgkin's disease (stages III and
IV), lymphocytic lymphoma, histiocytic lymphoma, mycosis fungoides,
advance testicular carcinoma, Kaposi's sarcoma, Letterer-Siwe disease
Palliative treatment of choriocarcinoma, breast cancer unresponsive to
Hodgkin's disease (advanced) alone or in combination therapies
Advanced testicular germinal-cell cancers alone or in combination
Contraindicated in the presence of allergy to vinblastine, leukopenia,
acute infection, pregnancy, lactation.
Use caution in the presence of liver disease.
Are you a doctor or a nurse?
Do you want to join the Doctors Lounge online medical community?
Participate in editorial activities (publish, peer review, edit) and
give a helping hand to the largest online community of patients.
Click on the link below to see the requirements:
Doctors Lounge Membership
- CNS: Numbness, paresthesias, peripheral neuritis, mental depression,
loss of deep tendon reflexes, headache, seizures, malaise, weakness,
- GI: Nausea, vomiting, pharyngitis, vesiculation of the mouth, ileus,
diarrhea, constipation, anorexia, abdominal pain, rectal bleeding,
- Hematologic: Leukopenia
- GU: Aspermia
- Dermatologic: Topical epilation (loss of hair), vesiculation of the skin
- Local: Local cellulitis, phlebitis, sloughing of the skin if
- Other: Pain in tumor site Pregnancy Category D